1. Functional outcome after long-term low-dose trimethoprim/sulfamethoxazole in chronic rhinosinusitis with purulence: a prospective study.
- Author
-
de Bonnecaze, G, Serrano, E, Vergez, S, Chaput, B, and Dupret-Bories, A
- Subjects
- *
CHRONIC diseases , *CO-trimoxazole , *ENDOSCOPY , *LONGITUDINAL method , *QUESTIONNAIRES , *SINUSITIS , *STAPHYLOCOCCUS aureus , *SUPPURATION , *TREATMENT effectiveness , *TREATMENT duration , *TERTIARY care , *DIAGNOSIS , *THERAPEUTICS - Abstract
Objective: Trimethoprim/sulfamethoxazole has been suggested as a treatment option for chronic rhinosinusitis with purulence. This study aimed to assess the functional and endoscopic outcomes after a three-month course of low-dose trimethoprim/sulfamethoxazole. Methods: A prospective study was performed, comprising patients referred to a tertiary care medical centre with a diagnosis of chronic rhinosinusitis with purulence. Trimethoprim/sulfamethoxazole was prescribed at 960 mg/day for three months. Sinonasal complaints and endoscopic findings were documented, and bacteriological data were compared. Results: Fifteen patients were included. Staphylococcus aureus was the most common bacterium cultured (86 per cent). Improvement in nasal function, as measured by the 22-item Sino-Nasal Outcome Test, was highly significant at three months (p < 0.0005). This improvement slightly decreased but remained significant at 6, 9 and 12 months. No side effects were noted. Endoscopic scores revealed similar and concordant improvements. Conclusion: Long-term low-dose trimethoprim/sulfamethoxazole therapy seems to be a safe option for selected patients. Additional randomised multicentre studies remain necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF